ArticleNature immunology2024
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.
Open access · hybridAbstract read
In one paragraph
Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Single-cell mapping of thymus-dependent naïve t-cell regeneration reveals CD61-associated states after hematopoietic stem cell transplantation.Experimental hematology & oncology · 2026Article
- Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Spatiotemporal immune dynamics in lung cancer progression and treatment.Breathe (Sheffield, England) · 2026Review
- Expression of CD103 facilitates localization and activation of CD4Mucosal immunology · 2026Article
- Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.Cancer immunology research · 2026Article
- The antitumor mechanism of immuno-flap treatment in a rat model of head and neck cancer.Cancer immunology, immunotherapy : CII · 2025Article
- A single-cell transcriptomic study of milk cells from dairy cows with divergent lactation performance.Scientific reports · 2025Article
- Tumor-specific CD8 T cell characterization in HRCell reports. Medicine · 2025Article
- Weight Loss Reverses the Effects of Aging and Obesity on Mammary Tumor Immunosuppression and Progression.Cancer prevention research (Philadelphia, Pa.) · 2025Article
- Memory-promoting function of miR-379-5p attenuates CD8Journal for immunotherapy of cancer · 2025Article
- Focusing on CD8Journal of experimental & clinical cancer research : CR · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors at 6 institutions in 3 countries.
Megat H B A Hamid *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-9072-1367
Pablo F Cespedes *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1641-4107
Chen Jin *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ji-Li Chen *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Uzi Gileadi *MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7348-9204
Elie Antoun *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Zhu Liang *CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8223-5003
Fei GaoCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2492-8586
Renuka TeagueCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nikita ManoharanCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
David Maldonado-PerezCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nasullah Khalid-AlhamInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.
Lucia CerundoloNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Raul CiaocaCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Svenja S HesterTarget Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Adán Pinto-FernándezCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Simeon D DraganovCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Iolanda VendrellCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Guihai LiuCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Xuan YaoCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Audun KvalvaagKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Delaney C C Dominey-FoyCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-9209-323X
Charunya NanayakkaraCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0007-2191-3086
Nikolaos KanellakisCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0065-2282
Yi-Ling ChenCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3758-0638
Craig WaughFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Sally-Ann ClarkFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1720-7975
Kevin ClarkFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Paul SoppFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Najib M RahmanCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1195-1680
Clare VerrillCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Benedikt M KesslerCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8160-2446
Graham OggCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ricardo A FernandesCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5343-3334
Roman FisherCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-9715-5951
Yanchun PengCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Michael L DustinCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4983-6389
Tao DongCAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. tao.dong@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0003-3545-3758
University of Oxford · GBChurchill Hospital · GBJohn Radcliffe Hospital · GBCentre for Human Genetics · GBMolecular Discovery (United Kingdom) · GBOslo University Hospital · NO
Funding
Chinese Academy of Medical Sciences (CAMS) 2018-I2M-002
Abstract
Cancer remains one of the leading causes of mortality worldwide, leading to increased interest in utilizing immunotherapy strategies for better cancer treatments. In the past decade, CD103
Indexed as
Antigens, CDApyraseIntegrin alpha ChainsReceptors, Antigen, T-CellSignal TransductionAnimalsCell Line, TumorCytotoxicity, ImmunologicHumansIntegrin beta3Lymphocytes, Tumor-InfiltratingMiceNeoplasmsT-Lymphocytes, Cytotoxicalpha E integrinsAntigens, CDApyraseENTPD1 protein, humanIntegrin alpha ChainsIntegrin beta3ITGB3 protein, humanReceptors, Antigen, T-Cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.